High-Risk Neuroblastoma Treatment Review
Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-08-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2227-9067/5/9/114 |
| _version_ | 1818349089997193216 |
|---|---|
| author | Valeria Smith Jennifer Foster |
| author_facet | Valeria Smith Jennifer Foster |
| author_sort | Valeria Smith |
| collection | DOAJ |
| description | Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survival rates. The current treatment schema is divided into three stages—induction, consolidation, and maintenance. This review serves as an overview of the current treatment for high-risk neuroblastoma and a glimpse at current research for future therapy. |
| first_indexed | 2024-12-13T18:00:25Z |
| format | Article |
| id | doaj.art-25c61f34367d4244983f86af5d5ff8ed |
| institution | Directory Open Access Journal |
| issn | 2227-9067 |
| language | English |
| last_indexed | 2024-12-13T18:00:25Z |
| publishDate | 2018-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Children |
| spelling | doaj.art-25c61f34367d4244983f86af5d5ff8ed2022-12-21T23:36:13ZengMDPI AGChildren2227-90672018-08-015911410.3390/children5090114children5090114High-Risk Neuroblastoma Treatment ReviewValeria Smith0Jennifer Foster1Baylor College of Medicine Department of Pediatrics, Texas Children’s Cancer and Hematology Center, Houston, TX 77030, USABaylor College of Medicine Department of Pediatrics, Texas Children’s Cancer and Hematology Center, Houston, TX 77030, USANeuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survival rates. The current treatment schema is divided into three stages—induction, consolidation, and maintenance. This review serves as an overview of the current treatment for high-risk neuroblastoma and a glimpse at current research for future therapy.http://www.mdpi.com/2227-9067/5/9/114neuroblastomahigh-risk neuroblastomadiagnosistreatment |
| spellingShingle | Valeria Smith Jennifer Foster High-Risk Neuroblastoma Treatment Review Children neuroblastoma high-risk neuroblastoma diagnosis treatment |
| title | High-Risk Neuroblastoma Treatment Review |
| title_full | High-Risk Neuroblastoma Treatment Review |
| title_fullStr | High-Risk Neuroblastoma Treatment Review |
| title_full_unstemmed | High-Risk Neuroblastoma Treatment Review |
| title_short | High-Risk Neuroblastoma Treatment Review |
| title_sort | high risk neuroblastoma treatment review |
| topic | neuroblastoma high-risk neuroblastoma diagnosis treatment |
| url | http://www.mdpi.com/2227-9067/5/9/114 |
| work_keys_str_mv | AT valeriasmith highriskneuroblastomatreatmentreview AT jenniferfoster highriskneuroblastomatreatmentreview |